Lista de obras -

A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction

artículo científico publicado en 2020

Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy

artículo científico publicado en 2009

Gut Microbiota Linked to Sexual Preference and HIV Infection.

artículo científico publicado en 2016

High Prevalence of Sarcopenia in HIV-Infected Individuals

article

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

artículo científico publicado en 2010

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

artículo científico publicado en 2012

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

artículo científico publicado en 2018

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

artículo científico publicado en 2009

Long-term changes in bone mineral density after switching to a protease inhibitor monotherapy in HIV-infected subject

artículo científico publicado en 2015

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

article

Potential prescribing issues among older HIV-infected persons in a Mediterranean cohort: Does the current prevalence give cause for concern?

artículo científico publicado en 2020

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

artículo científico publicado en 2016

Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC.

artículo científico publicado en 2014

Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances.

artículo científico publicado en 2006

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.

artículo científico publicado en 2016

Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients

artículo científico publicado en 2015

The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial

artículo científico publicado en 2015

Therapeutic management of bone demineralization in the HIV-infected population

artículo científico publicado en 2007

Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan

artículo científico publicado en 2012

Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort

artículo científico publicado en 2010

Lista de obras de

A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction

Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy

Gut Microbiota Linked to Sexual Preference and HIV Infection.

High Prevalence of Sarcopenia in HIV-Infected Individuals

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

Long-term changes in bone mineral density after switching to a protease inhibitor monotherapy in HIV-infected subject

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

Potential prescribing issues among older HIV-infected persons in a Mediterranean cohort: Does the current prevalence give cause for concern?

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC.

Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances.

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.

Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients

The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial

Therapeutic management of bone demineralization in the HIV-infected population

Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan

Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort